India, Sept. 1 -- Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies, which is exploring a new use for its CyPath Lung test in monitoring lung cancer patients after treatment; and Telix Pharmaceuticals, which completed enrollment in its Phase 3 BiPASS study of PSMA-PET imaging agents for prostate cancer detection before biopsy, among others.
Read on.
Universe Pharmaceuticals INC ( ATYR, BIAF, MAIA, MODD, TLX,TLX.AX, UPC) surged more than 30% in after-hours trading on Tuesday, following the submission of multiple Schedule 13G filings on September 1, 2026.
Schedule 13G filings disclose beneficial ownership of m...